We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 230,111 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/5/2017 15:48 | Or this I posted - 10 Dec 2016 Johnson & Johnson Innovation team up with Manchester scientists Since 19 Jun 2014 As part of a strategy to explore the emerging science around the human microbiome and its impact across several areas of health and disease, Johnson & Johnson Consumer & Personal Products Worldwide and Johnson & Johnson Innovation have established a collaboration with scientists from The University of Manchester. The collaboration will explore potential applications of probiotic extracts for prevention and treatment of skin, oral, and respiratory conditions. Dr Catherine ONeill, from the University's Institute of Inflammation and Repair, and Dr Andrew McBain, from Manchester Pharmacy School, will lead on the research project with Johnson & Johnson Innovation. Dr O'Neill said: It's exciting to be working with such a massive global player who we hope will really help us to develop products which will bring benefits to patients. "This collaboration will help us co-develop a piece of technology established here in Manchester which uses probiotics" or friendly bacteria - on the skin and hopefully take this to market. The agreement underscores the approach Johnson & Johnson Innovation is taking to establish scientific collaborations in areas that span its pharmaceutical, medical device and diagnostics and consumer businesses. | elrico | |
20/5/2017 15:13 | Once a Troll, always a Troll. All he can manage is 1 line and sometimes just 1 word. Spending so much time on calling everyone who post's something of interest, a ramper. Monkeywench1, seemingly of low intelligence can not come up with any meaningful debate, hence the 1 word/1line post of scorn. | lukead | |
20/5/2017 15:08 | someuwin, you can now ban the monkey now is no long a premium member. | slartybartfaster | |
20/5/2017 14:04 | I cant find the post or poster but i found this. someuwin - 27 Feb 2015 - 14:11:56 - 591 of 23861 OptiBiotix - Better Science, Better Health. Better buy some! - OPTI There's a land grab going on in this niche sector. Johnson & Johnson and Nestle have both made multi million $ moves already this year. This new science is red hot and there will be many big names looking at OPTI. | incanus | |
20/5/2017 11:40 | Someone else mentioned the johnson & johnson and alliance boots were established around the same time. I wonder if both collaborations could yield commercial terms by late 2018? They also mentioning johnson & johnson had done a lot of work with uom, on this basis it would be hard to see them walk away after investing time and money without it proving productive. Sorry but i can't recall who it was. | incanus | |
20/5/2017 10:14 | Trotters mentioned the UOM/J&J link earlier in the week, let's not forget UOM also have a relationship with Alliance Boots - another potential future partner for SBTX: Alliance Boots and The University of Manchester renew partnership 17 Jul 2014 Five year skin research programme to help further develop the understanding of skin ageing. Alliance Boots and The University of Manchester announce they have renewed their partnership in order to build on the highly successful work already achieved between the two organisations. This new five year partnership, which will run until the end of 2018, aims to further investigate the mechanisms by which human skin ages and, in turn, help boost innovation within Boots product brands. | parob | |
20/5/2017 08:17 | El, Morning :) | judijudi | |
19/5/2017 23:52 | lol. You know when someone has a limited vocabulary when they use the same 10 words in a different order or just add a name in the sentence. When has lukead offered an opinion of sbtx or opti? answer, he has not, so how can he ba called a ramper! Someone needs to get a life outside advfn, sad little man. | incanus | |
19/5/2017 23:42 | JJ - Harsh...Belgrano may well have a taste for the Iron Maiden trooper ale. I know from first hand in my case),it can turn the brain "cell." | elrico | |
19/5/2017 22:17 | el, Belgrano talks about a 3 year hold then a 6 month the a 3 years bottom draw Shyte imho | judijudi | |
19/5/2017 18:25 | Belgrano - you used to be indecisive but now you don't seem sure!Bottom draw for how long and hold for how long ;-) | elrico | |
19/5/2017 18:05 | Good week for SBTX. Up 30% over the week. | parob | |
19/5/2017 15:56 | yes it did elrico, however i'm not complaining as i managed to snaffle up a small modest holding during the dip, which is now in the btm drawer for a three year hold. i'll be happy to hold at this for another 6 months. company is well funded, might see some more investment opportunities yet as forced sellers off load in the interim. | belgrano2 | |
19/5/2017 12:20 | Another little tick up from here and a period of consolidation would do wonders. IF OPTI hold true to form and release a very positive commercial contract next week, SBTX will almost certainly continue to recover for the heady early high post IPO. To be fair, SBTX ran too quickly so the inevitable was bound to happen. | elrico | |
19/5/2017 11:02 | Nice trading session again this morning with the share price gradually ticking up again. Buying started now at 13.5p. 13.50 +0.75 (5.88%) Real-time: 11:00AM GMT+1 LON real-time data - Disclaimer Currency in GBX unless noted Range 12.62 - 13.50 52 week 9.33 - 17.75 Open 12.75 Vol / Avg. 249,216.00/657,070.0 Mkt cap 16.19M | ibug | |
19/5/2017 10:40 | lukead - you are a simple ramper. | monkeywench1 | |
19/5/2017 10:40 | slartybarty following my every move lol. | monkeywench1 | |
19/5/2017 09:19 | Aww how cute, monkeystench is following a certain poster, seeking attention are we. lol | slartybartfaster | |
18/5/2017 18:10 | Monkeywench, you are no bully as some would have you, you are just but a simple troll. | lukead | |
18/5/2017 17:14 | Whatever it does it won't be because of the rampers on here and opti. | monkeywench1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions